Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 293

1.

Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype.

Cini G, Quaia M, Canzonieri V, Fornasarig M, Maestro R, Morabito A, D'Elia AV, Urso ED, Mammi I, Viel A.

Mol Genet Genomic Med. 2019 May;7(5):e587. doi: 10.1002/mgg3.587. Epub 2019 Mar 27.

2.

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo.

Ni J, Cozzi P, Beretov J, Duan W, Bucci J, Graham P, Li Y.

BMC Cancer. 2018 Nov 12;18(1):1092. doi: 10.1186/s12885-018-5010-5.

3.
4.

Expression of EpCAM in adenoid cystic carcinoma.

Lee SJ, Chung KY, Kwon JE, Yoon SO, Kim SK.

Pathology. 2018 Dec;50(7):737-741. doi: 10.1016/j.pathol.2018.08.013. Epub 2018 Oct 30.

5.

EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion.

Gaber A, Kim SJ, Kaake RM, Benčina M, Krogan N, Šali A, Pavšič M, Lenarčič B.

Sci Rep. 2018 Sep 5;8(1):13269. doi: 10.1038/s41598-018-31482-7.

6.

Functions of EpCAM in physiological processes and diseases (Review).

Huang L, Yang Y, Yang F, Liu S, Zhu Z, Lei Z, Guo J.

Int J Mol Med. 2018 Oct;42(4):1771-1785. doi: 10.3892/ijmm.2018.3764. Epub 2018 Jul 11. Review.

7.

Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.

Liang KH, Tso HC, Hung SH, Kuan II, Lai JK, Ke FY, Chuang YT, Liu IJ, Wang YP, Chen RH, Wu HC.

Cancer Lett. 2018 Oct 1;433:165-175. doi: 10.1016/j.canlet.2018.06.040. Epub 2018 Jul 4.

PMID:
29981429
8.

EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.

Noh CK, Wang HJ, Kim CM, Kim J, Yoon SY, Lee GH, Cho HJ, Yang MJ, Kim SS, Hwang JC, Cho SW, Roh J, Kim YB, Kim SJ, Kim BW, Cheong JY.

Anticancer Res. 2018 Jul;38(7):4101-4109. doi: 10.21873/anticanres.12700.

PMID:
29970536
9.

EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.

Herreros-Pomares A, Aguilar-Gallardo C, Calabuig-Fariñas S, Sirera R, Jantus-Lewintre E, Camps C.

Crit Rev Oncol Hematol. 2018 Jun;126:52-63. doi: 10.1016/j.critrevonc.2018.03.006. Epub 2018 Mar 21. Review.

PMID:
29759567
10.

Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.

Wang MH, Sun R, Zhou XM, Zhang MY, Lu JB, Yang Y, Zeng LS, Yang XZ, Shi L, Xiao RW, Wang HY, Mai SJ.

Cell Death Dis. 2018 Jan 5;9(1):2. doi: 10.1038/s41419-017-0013-8.

11.

Epithelial cell adhesion molecule fragments and signaling in primary human liver cells.

Gerlach JC, Foka HG, Thompson RL, Gridelli B, Schmelzer E.

J Cell Physiol. 2018 Jun;233(6):4841-4851. doi: 10.1002/jcp.26286. Epub 2017 Dec 26.

PMID:
29150960
12.

Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.

Pachmann K, Willecke-Hochmuth R, Schneider K, Kaatz M.

Melanoma Res. 2018 Feb;28(1):37-43. doi: 10.1097/CMR.0000000000000407.

PMID:
29076925
13.

CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma.

Hoe SLL, Tan LP, Abdul Aziz N, Liew K, Teow SY, Abdul Razak FR, Chin YM, Mohamed Shahrehan NA, Chu TL, Mohd Kornain NK, Peh SC, Koay CE, Lo KW, Ahmad M, Ng CC, Khoo AS.

Sci Rep. 2017 Sep 28;7(1):12372. doi: 10.1038/s41598-017-12045-8.

14.

EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

van der Fels CAM, Rosati S, de Jong IJ.

Int J Mol Sci. 2017 Aug 18;18(8). pii: E1802. doi: 10.3390/ijms18081802.

15.

CD326 (EpCAM) testing by flow cytometric BerEP4 antibody is a useful and rapid adjunct to histopathology.

Dorwal P, Moore H, Stewart P, Harrison B, Monaghan J.

Cytometry B Clin Cytom. 2018 May;94(3):536-541. doi: 10.1002/cyto.b.21543. Epub 2017 Jul 28.

16.

Genomic analysis of an infant with intractable diarrhea and dilated cardiomyopathy.

Bodian DL, Vilboux T, Hourigan SK, Jenevein CL, Mani H, Kent KC, Khromykh A, Solomon BD, Hauser NS.

Cold Spring Harb Mol Case Stud. 2017 Nov 21;3(6). pii: a002055. doi: 10.1101/mcs.a002055. Print 2017 Nov.

17.

Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor Cells.

Athyala PK, Kanwar JR, Chitipothu S, Kanwar RK, Krishnakumar S, Watson JP, Narayanan J.

Anticancer Res. 2017 Jul;37(7):3615-3629.

PMID:
28668853
18.

EpCAM-expressing circulating tumor cells in colorectal cancer.

Nicolazzo C, Raimondi C, Francescangeli F, Ceccarelli S, Trenta P, Magri V, Marchese C, Zeuner A, Gradilone A, Gazzaniga P.

Int J Biol Markers. 2017 Oct 31;32(4):e415-e420. doi: 10.5301/ijbm.5000284.

PMID:
28604994
19.

The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer.

Tayama S, Motohara T, Narantuya D, Li C, Fujimoto K, Sakaguchi I, Tashiro H, Saya H, Nagano O, Katabuchi H.

Oncotarget. 2017 Jul 4;8(27):44312-44325. doi: 10.18632/oncotarget.17871.

20.

Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.

Han S, Zong S, Shi Q, Li H, Liu S, Yang W, Li W, Hou F.

EBioMedicine. 2017 Jun;20:61-69. doi: 10.1016/j.ebiom.2017.05.025. Epub 2017 May 24.

Supplemental Content

Support Center